Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 696389402 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Commodore Capital LP
13G/A
Amendment 2
|
0% |
8/14/2026
Event 6/30/2026
|
|
| Commodore Capital LP | 0% | ||
| Commodore Capital Master LP | 0% | ||
| Robert Egen Atkinson | 0% | ||
| Michael Kramarz | 0% | ||
|
Soleus Capital Master Fund, L.P.
13G/A
Amendment 1
|
7.5% |
8/13/2026
Event 6/30/2026
|
|
| Soleus Capital Master Fund, L.P. | 7.5% | ||
| Soleus Capital, LLC | 7.5% | ||
| Soleus Capital Group, LLC | 7.5% | ||
| Soleus Capital Management, L.P. | 7.5% | ||
| Soleus GP, LLC | 7.5% | ||
| Guy Levy | 7.5% | ||
| BlackRock, Inc. 13G | 6.0% |
7/29/2026
Event 6/30/2026
|
|
|
Soleus Capital Master Fund, L.P.
13G
|
5.4% |
5/27/2026
Event 5/26/2026
|
|
| Soleus Capital Master Fund, L.P. | 5.4% | ||
| Soleus Capital, LLC | 5.4% | ||
| Soleus Capital Group, LLC | 5.4% | ||
| Soleus Capital Management, L.P. | 5.4% | ||
| Soleus GP, LLC | 5.4% | ||
| Guy Levy | 5.4% | ||
|
Commodore Capital LP
13G/A
Amendment 1
|
7.2% |
5/15/2026
Event 3/31/2026
|
|
| Commodore Capital LP | 7.2% | ||
| Commodore Capital Master LP | 7.2% | ||
| Robert Egen Atkinson | 7.2% | ||
| Michael Kramarz | 7.2% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 2
|
9.9% |
5/15/2026
Event 3/31/2026
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 2
|
7.9% |
5/15/2026
Event 3/31/2026
|
|
| Perceptive Advisors LLC | 7.9% | ||
| Joseph Edelman | 7.9% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 7.9% | ||
|
Ameriprise Financial, Inc.
13G
|
5.3% |
5/15/2026
Event 3/31/2026
|
|
| Ameriprise Financial, Inc. | 5.3% | ||
| Columbia Management Investment Advisers, LLC | 5.3% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 2
|
0.2% |
5/15/2026
Event 3/31/2026
|
|
| Point72 Asset Management, L.P. | 0.2% | ||
| Point72 Capital Advisors, Inc. | 0.2% | ||
| Steven A. Cohen | 0.2% | ||
|
Squadron Capital Management LLC
13G/A
Amendment 1
|
3.0% |
2/17/2026
Event 12/31/2025
|
|
| Squadron Master Fund LP | 3.0% | ||
| Squadron Capital Management LLC | 3.0% | ||
| Matthew Sesterhenn | 3.0% | ||
| William Blank | 3.0% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 1
|
9.9% |
2/17/2026
Event 12/31/2025
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 1
|
10.0% |
2/17/2026
Event 12/31/2025
|
|
| Perceptive Advisors LLC | 10.0% | ||
| Joseph Edelman | 10.0% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 1
|
7.0% |
2/17/2026
Event 12/31/2025
|
|
| Point72 Asset Management, L.P. | 7.0% | ||
| Point72 Capital Advisors, Inc. | 7.0% | ||
| Steven A. Cohen | 7.0% | ||
|
Deep Track Capital, LP
13G/A
Amendment 1
|
0% |
2/13/2026
Event 12/31/2025
|
|
| Deep Track Capital, LP | 0% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 0% | ||
| David Kroin | 0% | ||
| Deep Track Special Opportunities Fund, LP. | 0% | ||
|
Octagon Capital Advisors LP
13G
|
6.4% |
2/10/2026
Event 12/31/2025
|
|
| Octagon Capital Advisors LP | 6.4% | ||
| Octagon Investments Master Fund LP | 6.4% | ||
| Ting Jia | 6.4% | ||
|
Franklin Resources, Inc.
13G
|
6.0% |
1/29/2026
Event 12/31/2025
|
|
| Franklin Resources, Inc. | 6.0% | ||
| Charles B. Johnson | 0% | ||
| Rupert H. Johnson, Jr. | 0% | ||
| Franklin Advisers, Inc. | 6.0% | ||
|
Janus Henderson Group PLC
13G
|
10.0% |
12/8/2025
Event 11/28/2025
|
|
| Janus Henderson Group PLC | 10.0% | ||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.0% | ||
|
RA Capital Management, L.P.
13G
|
9.9% |
10/9/2025
Event 10/2/2025
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
Perceptive Advisors LLC
13G
|
10.0% |
10/9/2025
Event 10/2/2025
|
|
| Perceptive Advisors LLC | 10.0% | ||
| Joseph Edelman | 10.0% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | ||
|
Squadron Capital Management LLC
13G
|
8.5% |
10/8/2025
Event 10/1/2025
|
|
| Squadron Master Fund LP | 7.6% | ||
| Squadron Capital Management LLC | 8.5% | ||
| Matthew Sesterhenn | 8.5% | ||
| William Blank | 8.5% | ||
|
Commodore Capital LP
13G
|
9.9% |
10/8/2025
Event 10/1/2025
|
|
| Commodore Capital LP | 9.9% | ||
| Commodore Capital Master LP | 9.9% | ||
| Robert Egen Atkinson | 9.9% | ||
| Michael Kramarz | 9.9% | ||
|
Deep Track Capital, LP
13G
|
10.0% |
10/8/2025
Event 10/1/2025
|
|
| Deep Track Capital, LP | 10.0% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 6.5% | ||
| David Kroin | 10.0% | ||
| Deep Track Special Opportunities Fund, LP. | 3.5% | ||
|
Point72 Asset Management, L.P.
13G
|
6.2% |
10/7/2025
Event 10/6/2025
|
|
| Point72 Asset Management, L.P. | 6.2% | ||
| Point72 Capital Advisors, Inc. | 6.2% | ||
| Steven A. Cohen | 6.2% | ||
|
Armistice Capital, LLC
13G/A
Amendment 2
|
10.0% |
5/15/2025
Event 3/31/2025
|
|
| Armistice Capital, LLC | 10.0% | ||
| Steven Boyd | 10.0% | ||
|
Armistice Capital, LLC
13G/A
Amendment 1
|
10.0% |
2/14/2025
Event 12/31/2024
|
|
| Armistice Capital, LLC | 10.0% | ||
| Steven Boyd | 10.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 4.74 k | $6.41 k |
| 2026 Q2 | 125 | 173 M | $364 M |
| 2026 Q1 | 96 | 149 M | $262 M |
| 2025 Q4 | 87 | 136 M | $319 M |
| 2025 Q3 | 12 | 120 k | $103 k |
| 2025 Q2 | 12 | 84.6 k | $57.5 k |
| 2025 Q1 | 14 | 296 k | $201 k |
| 2024 Q4 | 11 | 235 k | $388 k |
| 2024 Q3 | 11 | 106 k | $377 k |
| 2024 Q2 | 10 | 66.0 k | $298 k |